Subjective Responses to Alcohol in the Development and Maintenance of Alcohol Use Disorder.


Journal

The American journal of psychiatry
ISSN: 1535-7228
Titre abrégé: Am J Psychiatry
Pays: United States
ID NLM: 0370512

Informations de publication

Date de publication:
06 2021
Historique:
pubmed: 6 1 2021
medline: 27 7 2021
entrez: 5 1 2021
Statut: ppublish

Résumé

Alcohol use disorder (AUD) remains an urgent public health problem. Longitudinal data are needed to clarify the role of acute subjective responses to alcohol in the development and maintenance of excessive drinking and AUD. The authors report on 10 years of repeated examination of acute alcohol responses in the Chicago Social Drinking Project. Young adult drinkers (N=190) participated in an initial alcohol challenge (0.8 g/kg of alcohol compared with placebo) that was repeated 5 and 10 years later. They were also assessed on drinking behavior and AUD symptoms at numerous intervals across the decade. Retention was high, as 184 of the 185 (99%) nondeceased active participants completed the 10-year follow-up, and 91% (163 of 179) of those eligible for alcohol consumption engaged in repeated laboratory testing during this interval. At the end of the decade, 21% of participants met criteria for past-year AUD. Individuals who reported the greatest alcohol stimulation, liking, and wanting at the initial alcohol challenge were most likely to have developed AUD 10 years later. Further, alcohol-induced stimulation and wanting increased in reexamination testing among those with the highest AUD symptoms as the decade progressed. Initial stimulant and rewarding effects of alcohol predicted heavy alcohol use, and the magnitude of these positive subjective effects increased over a 10-year period in those who developed AUD compared with those who did not develop the disorder. The findings demonstrate systematic changes in subjective responses to alcohol over time, providing an empirical basis for prevention, early intervention, and treatment strategies.

Identifiants

pubmed: 33397141
doi: 10.1176/appi.ajp.2020.20030247
pmc: PMC8222099
mid: NIHMS1673213
doi:

Substances chimiques

Central Nervous System Depressants 0
Ethanol 3K9958V90M

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

560-571

Subventions

Organisme : NIDA NIH HHS
ID : T32 DA043469
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA023839
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA018652
Pays : United States
Organisme : NIAAA NIH HHS
ID : P60 AA007611
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA013746
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA025309
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA002812
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Alcohol Clin Exp Res. 2002 Jun;26(6):827-35
pubmed: 12068251
Neuropsychopharmacology. 2018 Aug;43(9):1891-1899
pubmed: 29802367
Arch Gen Psychiatry. 1973 Feb;28(2):238-43
pubmed: 4684290
Psychopharmacology (Berl). 2005 Apr;178(4):493-9
pubmed: 15517194
Addiction. 2005 Jun;100(6):806-19
pubmed: 15918811
Am J Psychiatry. 1994 Feb;151(2):184-9
pubmed: 8296886
Neuropsychopharmacology. 2000 May;22(5):480-92
pubmed: 10731623
Psychopharmacology (Berl). 1980;71(3):269-73
pubmed: 6779334
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
Alcohol Clin Exp Res. 2009 Sep;33(9):1508-12
pubmed: 19519721
JAMA Psychiatry. 2017 Sep 1;74(9):911-923
pubmed: 28793133
BJPsych Open. 2019 Apr 22;5(3):e38
pubmed: 31685074
Drug Alcohol Depend. 2019 Dec 1;205:107590
pubmed: 31600616
Alcohol Clin Exp Res. 1990 Jun;14(3):421-4
pubmed: 2378426
Alcohol Clin Exp Res. 1993 Feb;17(1):140-6
pubmed: 8452195
Neuropsychopharmacology. 2012 Jan;37(2):467-77
pubmed: 21956438
Alcohol Clin Exp Res. 2006 Feb;30(2):243-52
pubmed: 16441273
Alcohol Clin Exp Res. 2000 Dec;24(12):1820-9
pubmed: 11141041
Arch Gen Psychiatry. 2011 Apr;68(4):389-99
pubmed: 21464363
Alcohol Clin Exp Res. 2016 Jan;40(1):6-17
pubmed: 26727518
Brain Res Brain Res Rev. 1998 Dec;28(3):309-69
pubmed: 9858756
Exp Clin Psychopharmacol. 2014 Feb;22(1):43-9
pubmed: 24490710
Biol Psychiatry. 2016 Mar 15;79(6):489-98
pubmed: 26117308
Psychol Med. 2006 Jul;36(7):931-41
pubmed: 16563205
J Neurosci. 2008 Apr 30;28(18):4583-91
pubmed: 18448634
Exp Clin Psychopharmacol. 2012 Oct;20(5):382-9
pubmed: 22867037
Psychol Addict Behav. 2010 Mar;24(1):157-62
pubmed: 20307124
Biol Psychiatry. 2014 May 15;75(10):754-5
pubmed: 24780011
J Consult Clin Psychol. 2002 Feb;70(1):67-78
pubmed: 11860058
PLoS Med. 2019 Nov 26;16(11):e1002954
pubmed: 31770389
Biol Psychiatry. 2014 May 15;75(10):798-806
pubmed: 24094754
Alcohol Clin Exp Res. 2009 May;33(5):916-24
pubmed: 19320625
Neuropharmacology. 2017 Aug 1;122:3-21
pubmed: 28118990
Int J Psychophysiol. 2006 Mar;59(3):203-9
pubmed: 16359745
Alcohol Res Health. 2011;34(2):135-43
pubmed: 22330211
Neuropsychopharmacology. 2000 Jun;22(6):581-94
pubmed: 10788758
Alcohol Clin Exp Res. 2005 Apr;29(4):547-52
pubmed: 15834219
Psychopharmacology (Berl). 2013 May;227(1):177-92
pubmed: 23271193
Alcohol Clin Exp Res. 2014 Dec;38(12):3024-32
pubmed: 25581657
Drug Alcohol Depend. 2014 Jul 1;140:161-7
pubmed: 24837580
Drug Alcohol Depend. 2007 Nov 2;91(1):10-7
pubmed: 17560739
Science. 1997 Oct 3;278(5335):52-8
pubmed: 9311926
JAMA. 2018 Aug 28;320(8):815-824
pubmed: 30167705
Alcohol Res Health. 2000;24(2):77-84
pubmed: 11199281
Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
pubmed: 8401595
Neurosci Biobehav Rev. 2019 Dec;107:897-926
pubmed: 31672617
Addiction. 2011 Oct;106(10):1718-24
pubmed: 21819471
Annu Rev Psychol. 2008;59:29-53
pubmed: 18154498
Psychopharmacology (Berl). 2001 Aug;157(1):20-30
pubmed: 11512039
Drug Alcohol Depend. 2017 Jun 1;175:171-178
pubmed: 28437721
Alcohol Clin Exp Res. 2009 May;33(5):938-44
pubmed: 19320632
Psychol Rev. 1987 Oct;94(4):469-92
pubmed: 3317472
Dialogues Clin Neurosci. 2017 Sep;19(3):247-258
pubmed: 29302222

Auteurs

Andrea King (A)

Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago (King, Vena, deWit); Department of Epidemiology, Mailman School of Public Health, and Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York (Hasin); Department of Psychiatry, Indiana University School of Medicine, Indianapolis, and Department of Biomedical Engineering, Purdue University, West Lafayette, Ind. (O'Connor); Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago (Cao).

Ashley Vena (A)

Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago (King, Vena, deWit); Department of Epidemiology, Mailman School of Public Health, and Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York (Hasin); Department of Psychiatry, Indiana University School of Medicine, Indianapolis, and Department of Biomedical Engineering, Purdue University, West Lafayette, Ind. (O'Connor); Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago (Cao).

Deborah S Hasin (DS)

Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago (King, Vena, deWit); Department of Epidemiology, Mailman School of Public Health, and Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York (Hasin); Department of Psychiatry, Indiana University School of Medicine, Indianapolis, and Department of Biomedical Engineering, Purdue University, West Lafayette, Ind. (O'Connor); Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago (Cao).

Harriet deWit (H)

Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago (King, Vena, deWit); Department of Epidemiology, Mailman School of Public Health, and Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York (Hasin); Department of Psychiatry, Indiana University School of Medicine, Indianapolis, and Department of Biomedical Engineering, Purdue University, West Lafayette, Ind. (O'Connor); Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago (Cao).

Sean J O'Connor (SJ)

Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago (King, Vena, deWit); Department of Epidemiology, Mailman School of Public Health, and Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York (Hasin); Department of Psychiatry, Indiana University School of Medicine, Indianapolis, and Department of Biomedical Engineering, Purdue University, West Lafayette, Ind. (O'Connor); Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago (Cao).

Dingcai Cao (D)

Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago (King, Vena, deWit); Department of Epidemiology, Mailman School of Public Health, and Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York (Hasin); Department of Psychiatry, Indiana University School of Medicine, Indianapolis, and Department of Biomedical Engineering, Purdue University, West Lafayette, Ind. (O'Connor); Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago (Cao).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH